Request FREE sample PDF ![PDF](https://www.businessresearchinsights.com/assets/img/popup-form/PDF.svg)
Pharmacy benefit management market
Poliovirus Vaccine Inactivated Market REPORT OVERVIEW
global poliovirus vaccine inactivated market size was USD 742.2 million in 2022 and market is projected to touch 1066.74 Million By 2031, exhibiting a CAGR of 4.1% during the forecast period.
Poliomyelitis is a contagious and contagious illness that invades the nerve system of the sufferer and can have paralyzing effects. Human enteroviruses from the Picornaviridae family are the culprits behind the illness. Because of poor sanitation and personal hygiene practices, contaminated food and water, as well as contact with sick individuals, are the main ways that polio is spread.
Three different poliovirus strains have been formalin-inactivated (killed) and are present in poliovirus vaccine inactivated It can be given subcutaneously or intramuscularly. Poliovirus vaccine inactivated must be administered by a qualified healthcare professional by intravenous or intradermal injection. It causes the blood to develop antibodies that are effective against all three poliovirus types. In the event of an infection, the antibodies created guard against paralysis by preventing the virus' progression to the brain and spinal cord.
COVID-19 Impact
"Supply and Isolation Limitations to Deplete Market Advancement "
The COVID-19 pandemic's emergence considerably accelerated the development of its vaccine. The market for poliomyelitis vaccines was hampered. The outbreak caused a minor setback for the poliovirus vaccine inactivated market. However, as cases declined and attention shifted to other illnesses and the discovery of vaccines in the post-pandemic era, poliovirus vaccine inactivated faced a rise and is anticipated to experience a significant increase in the coming years.
LATEST TRENDS
"Technological Advances to Stimulate Market Development "
The worldwide poliovirus vaccine inactivated market share is anticipated to rise as a result of technological advances and expanding research and development. In response to the WHO and governments allowing and promoting the utilization of inactivated vaccines, firms have introduced a number of new products. Additionally, Inactivated Polio Vaccine has no danger of VAPP and produces a highly effective protective immune response in the majority of recipients. As a result, the market has several prospects for expansion.
Poliovirus Vaccine Inactivated Market SEGMENTATION
- By Type
Based on type; the market is divided into human diploid cell, monkey kidney cell
Human diploid cell is the leading part of the type segment.
- By Application
Based on the application; the market is divided into public, private
Public is the leading part of the application segment.
DRIVING FACTORS
"Increase in the Presence of Retailer Pharmacies to Aid Market Expansion "
Opportunities for market growth are created by the increase in the amount of poliomyelitis medicines supplied by means of retail pharmacies along with the increase in the presence of retailer pharmacies in advanced countries. In addition, patients prefer retail pharmacies because of their accessibility when buying medications. In addition, government and non-government groups in underdeveloped nations have worked extremely hard in recent years to promote preventive medicine.
Numerous initiatives have been carried out to assist the uneducated, particularly in rural areas. For instance, the GPEI's Polio Eradication Strategy 2022–2026, which was introduced in 2020, has a specific objective for eliminating the last strain of WPV1, proving the absence of cVDPV2, and preparing for post-polio issues. This is a significant driver of the global market for bacterial vaccines in emerging economies.
"Involvement of Governmental Sector to Foster Industry Progress "
The market is divided between private and public segments based on the distribution channel. The market is being led by the public sector. The governmental sector is heavily involved in vaccination because it falls under the ambit of the welfare and health of the public. As more key market players engage in mergers and acquisitions, the market for poliomycetes vaccines is predicted to grow. For instance, Serum Institute India Private Limited Pvt. Ltd. purchased Czech company Nanotherapeutics for USD 82.08 million in April 2017. As a consequence of this acquisition, Serum Institute was capable of to increase its capacity to produce 200 million doses of injectable polio vaccine.
RESTRAINING FACTORS
"Ineffectiveness of Vaccine to Hinder Market Advancement "
Inactivated polio vaccinations are less effective for immunizing against polio, according to data from numerous research investigations. For example, inactivated polio vaccinations (IPV) impair intestinal immunity. In addition, everyone contracts the wild poliovirus after receiving IPV vaccination, which multiplies in the intestines. The poliomyelitis vaccinations' numerous negative effects undoubtedly hinder the market's expansion. The poliovirus vaccine inactivated market growth expansion is hampered by side effects like fever, chills, pain, soreness, and numerous other similar consequences.
Poliovirus Vaccine Inactivated Market REGIONAL INSIGHTS
"Increased Investment in North America to Support Market Advancement "
Due to the increased investment for research and development operations for the creation of vaccines, North America is anticipated to dominate the global poliovirus vaccine inactivated market by geography. Additionally, oral polio vaccines were no longer used in the U.S. as of the year 2000. The need for poliovirus vaccine inactivated has increased as a result. North America region will experience positive growth as a result of its enormous population and rising vaccination awareness.
KEY INDUSTRY PLAYERS
"Key Players Focus on Partnerships to Gain a Competitive Advantage"
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.
The analyst provides a comprehensive picture of the market through the study, synthesis, and summarization of data from various sources, as well as an examination of important variables such as financial gain, sales prices, competition, and promotions. It identifies the key industry influencers and presents various market facets. The information provided is thorough, reliable, and the result of extensive primary and secondary research. The market report provides a comprehensive competitive landscape as well as an in-depth vendor evaluation methodology and analysis based on both qualitative and quantitative studies to accurately forecast market growth.
The reports cover important advances with in market, as well as inorganic and organic growth strategies. Various companies are concentrating on organic business expansion such as product announcements, product approvals, and other things like patents and events. Acquisitions, partnerships, and collaborations were among the inorganic growth strategies observed in the market. The above activities have paved the way for market participants to expand their business and customer base. With the growing demands for filter products in the international market, market participants in the market are expected to benefit from substantial growth opportunities in the near future.
List of Market Players Profiled
- Sanofi (France)
- GSK (U.K.)
- Serum Institute (Bilthoven Biologicals) (U.S.)
- IMBCA (India)
REPORT COVERAGE
This research offers a thorough analysis of the global market, covering all relevant areas. This includes everything from a broad market overview to micro-level information about size of the market, degree of competition, evolution trend, opportunities in the market, important market drivers, and SWOT opportunities and threats. The reader can use the study to influence industry competitiveness and competitive environment strategies to increase potential profit. Additionally, it offers a straightforward framework for assessing and gaining access to the situation of the corporate organization.
In a nutshell, this study should be read by all market participants, traders, academics, analysts, business planners, and anyone else with an interest in the market. The market competitive landscape is another area that the report structure focuses on. This report presents in depth information the share of the market, macroeconomic indicators, product scenario, operation circumstances of the major players, which aids readers in the industry in recognizing the key rivals and better understanding the market's competitive landscape.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 742.2 Million in 2022 |
Market Size Value By |
US$ 1066.74 Million by 2031 |
Growth Rate |
CAGR of 4.1% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered | |
By Type
|
|
By Application
|
Frequently Asked Questions
-
What value is the poliovirus vaccine inactivated market expected to touch by 2031?
The global poliovirus vaccine inactivated market size is expected to reach USD 1066.74 Million By 2031
-
What CAGR is the poliovirus vaccine inactivated market expected to exhibit by 2031?
The poliovirus vaccine inactivated market is expected to exhibit a CAGR of 4.1% by 2031.
-
Which are the driving factors of the poliovirus vaccine inactivated market?
The driving factors of the poliovirus vaccine inactivated market are increase in the presence of retailer pharmacies involvement of governmental sector.
-
Which are the key players or most dominating companies functioning in the poliovirus vaccine inactivated market?
The key players or most dominating companies functioning in the poliovirus vaccine inactivated market are, Sanofi, GSK, Serum Institute (Bilthoven Biologicals), IMBCA